Prognostic Value of Biomarkers in Polyneuropathy.
ConditionPolyneuropathies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRigshospitalet, Denmark
About this trial
Biomarkers for prognosis of patients with polyneuropathy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Minimum 18 years old.
Diagnosed with polyneuropathy, confirmed by nerve conduction study.
Can read and understand Danish.
Disqualifiers
Inability to perform physical tests due to comorbidity not associated to the patient's polyneuropathy.
Trial population
Patients with acquired or hereditary polyneuropathy (ICD-10 diagnosis) confirmed at nerveconduction study.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Disease Severity
Primary outcome is disease severity
Time frame
2 yearsSecondary outcomes
1
Patient Reported Outcomes (PROMs)
Secondary outcome is patient reported outcomes.
Time frame
2 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov